Zhewitra: Effective Erectile Dysfunction Treatment with Vardenafil
Zhewitra
| Product dosage: 20 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | 0.88 $
Best per pill | 52.65 $ (0%) | 🛒 Add to cart |
Synonyms | |||
Zhewitra is a prescription medication containing Vardenafil, a potent PDE5 inhibitor, specifically formulated for the treatment of erectile dysfunction (ED). It works by increasing blood flow to the penis, facilitating the achievement and maintenance of an erection sufficient for sexual activity. This medication is intended for adult males and should be used under appropriate medical guidance. Clinical studies support its efficacy and safety profile when used as directed by a healthcare provider.
Features
- Active ingredient: Vardenafil 20mg
- Formulation: Oral tablet
- Onset of action: Typically within 25-60 minutes
- Duration of effect: Up to 4-5 hours
- Requires sexual stimulation for efficacy
- Available in blister packs for convenience and protection
Benefits
- Enables reliable and satisfactory erectile function
- Supports improved sexual confidence and relationship satisfaction
- Offers a discreet and convenient treatment option
- Provides a predictable and manageable therapeutic window
- May contribute to overall psychological well-being
- Backed by clinical evidence of safety and efficacy
Common use
Zhewitra is primarily indicated for the management of erectile dysfunction in adult males. It is used on an as-needed basis prior to anticipated sexual activity. The medication is not intended for use by women, children, or adolescents. It should only be used by individuals with a confirmed diagnosis of ED and after thorough medical evaluation to rule out underlying cardiovascular or other contraindications.
Dosage and direction
The recommended starting dose is 10mg taken orally approximately 25-60 minutes before sexual activity. Based on efficacy and tolerability, the dose may be increased to 20mg or decreased to 5mg. The maximum recommended dosing frequency is once per day. Tablets should be swallowed whole with a glass of water; they may be taken with or without food, though high-fat meals may delay onset of action. Do not crush or chew the tablet.
Precautions
Patients should undergo a thorough medical assessment before initiating treatment. Cardiovascular status should be evaluated as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical penile deformity, bleeding disorders, or active peptic ulceration. Priapism (prolonged erection >4 hours) requires immediate medical attention to prevent permanent damage. Sudden vision or hearing loss warrants discontinuation and prompt medical evaluation.
Contraindications
Concomitant use with nitrates or nitric oxide donors in any form. Hypersensitivity to Vardenafil or any excipients. Severe hepatic impairment (Child-Pugh C). End-stage renal disease requiring dialysis. History of non-arteritic anterior ischemic optic neuropathy (NAION). Concurrent use with potent CYP3A4 inhibitors in patients with cardiovascular instability. Unstable angina or recent myocardial infarction.
Possible side effects
- Headache (15%)
- Flushing (12%)
- Rhinitis (9%)
- Dyspepsia (5%)
- Dizziness (2%)
- Visual disturbances (2%)
- Back pain/myalgia (3%)
- Less common: palpitations, nasal congestion, nausea
- Rare: priapism, sudden hearing loss, NAION
Drug interaction
Contraindicated with nitrates. Use with caution with alpha-blockers (risk of hypotension). Potent CYP3A4 inhibitors (ketoconazole, ritonavir) increase Vardenafil exposure—dose adjustment required. Moderate CYP3A4 inhibitors (erythromycin) may require dose reduction. Inducers of CYP3A4 (rifampin) may decrease efficacy. Grapefruit juice may increase bioavailability. Concurrent use with other ED treatments not recommended.
Missed dose
Zhewitra is not intended for regular dosing. If a dose is missed, take it when remembered if sufficient time remains before sexual activity. Do not double the dose or take more than one tablet within 24 hours. The medication should only be taken when needed, not on a fixed schedule.
Overdose
Symptoms may include severe headache, visual disturbances, dizziness, syncope, and prolonged erection. Standard supportive measures should be employed. Hemodialysis not expected to enhance elimination due to high protein binding. Management of priapism requires immediate urological consultation. Symptomatic hypotension should be treated with volume expansion and positioning.
Storage
Store at 20-25°C (68-77°F). Excursions permitted to 15-30°C (59-86°F). Keep in original blister packaging to protect from light and moisture. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Do not transfer to alternative containers.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment recommendations. Individual results may vary. Not all possible uses, interactions, or adverse effects are listed here.
Reviews
“After struggling with ED for two years, Zhewitra has restored my confidence. The effect is consistent and predictable when taken as directed.” - Verified Patient
“As a urologist, I find Vardenafil-based treatments like Zhewitra offer a valuable option in our ED management arsenal, particularly for patients who need longer duration of action.” - Medical Professional
“Noticeable improvement within 40 minutes with minimal side effects. The 20mg dose provides reliable results without needing to plan too far in advance.” - Clinical Trial Participant
“Important to emphasize that proper medical screening is essential before use. When prescribed appropriately, this medication can significantly improve quality of life.” - Healthcare Provider